Ibopamine: D1-dopaminergic agonist in the diagnosis of glaucoma.

  title={Ibopamine: D1-dopaminergic agonist in the diagnosis of glaucoma.},
  author={Michele Virno and Roberto Sampaolesi and Jos{\`e} Pecori Giraldi and Fabio De Gregorio and Maurizio Taloni and Paolo Brusini and Silvio di Staso and Gaetano Stecchi},
  journal={Journal of glaucoma},
  volume={22 1},
PURPOSE The purpose of the study was to assess the effect of ibopamine (3,4 di-isobutyrrylester of N-methyldopamine), a D1-dopamine agonist, on intraocular pressure (IOP) in offspring of parents with primary openangle glaucoma as a consequence of outflow structures impairment. MATERIALS AND METHODS We included participants aged between 8 and 40 years: group 1, 163 offspring of at least 1 parent with primary openangle glaucoma with normal IOP and without glaucomatous damages; group 2, 108… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS